These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38643856)

  • 21. Vaccine protection against Zika virus from Brazil.
    Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
    Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia.
    Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S
    J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
    De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge.
    Sun E; Zhao J; TaoYang ; Xu Q; Qin Y; Wang W; Wei P; Wu D
    Vet Microbiol; 2013 Sep; 166(1-2):145-53. PubMed ID: 23834965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
    Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
    Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.
    Yang M; Dent M; Lai H; Sun H; Chen Q
    Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice.
    Liu X; Li Z; Li X; Wu W; Jiang H; Zheng Y; Zhou J; Ye X; Lu J; Wang W; Yu L; Li Y; Qu L; Wang J; Li F; Chen L; Wu L; Feng L
    Nat Commun; 2024 Oct; 15(1):8932. PubMed ID: 39414822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine mapping of a linear epitope on EDIII of Japanese encephalitis virus using a novel neutralizing monoclonal antibody.
    Deng WL; Guan CY; Liu K; Zhang XM; Feng XL; Zhou B; Su XD; Chen PY
    Virus Res; 2014 Jan; 179():133-9. PubMed ID: 24184444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL.
    Ricciardi MJ; Magnani DM; Grifoni A; Kwon YC; Gutman MJ; Grubaugh ND; Gangavarapu K; Sharkey M; Silveira CGT; Bailey VK; Pedreño-Lopez N; Gonzalez-Nieto L; Maxwell HS; Domingues A; Martins MA; Pham J; Weiskopf D; Altman J; Kallas EG; Andersen KG; Stevenson M; Lichtenberger P; Choe H; Whitehead SS; Sette A; Watkins DI
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006000. PubMed ID: 29267278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine.
    Li Y; Merbah M; Wollen-Roberts S; Beckman B; Mdluli T; Curtis DJ; Currier JR; Mendez-Rivera L; Dussupt V; Krebs SJ; De La Barrera R; Michael NL; Paquin-Proulx D; Eller MA; Koren MA; Modjarrad K; Rolland M
    EBioMedicine; 2023 Nov; 97():104815. PubMed ID: 37793212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement.
    Yen LC; Chen HW; Ho CL; Lin CC; Lin YL; Yang QW; Chiu KC; Lien SP; Lin RJ; Liao CL
    J Biomed Sci; 2023 Jun; 30(1):41. PubMed ID: 37316861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.
    Stettler K; Beltramello M; Espinosa DA; Graham V; Cassotta A; Bianchi S; Vanzetta F; Minola A; Jaconi S; Mele F; Foglierini M; Pedotti M; Simonelli L; Dowall S; Atkinson B; Percivalle E; Simmons CP; Varani L; Blum J; Baldanti F; Cameroni E; Hewson R; Harris E; Lanzavecchia A; Sallusto F; Corti D
    Science; 2016 Aug; 353(6301):823-6. PubMed ID: 27417494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
    Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
    Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice.
    Shim BS; Kwon YC; Ricciardi MJ; Stone M; Otsuka Y; Berri F; Kwal JM; Magnani DM; Jackson CB; Richard AS; Norris P; Busch M; Curry CL; Farzan M; Watkins D; Choe H
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus.
    Chen HW; Huang HW; Hu HM; Chung HH; Wu SH; Chong P; Tao MH; Pan CH
    J Gen Virol; 2014 Sep; 95(Pt 9):1983-1990. PubMed ID: 24914069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Appl Microbiol Biotechnol; 2012 Sep; 95(5):1179-89. PubMed ID: 22562165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.